Similar Stories to Bristol-myers: 2 Cancer Drugs Beat 1 Against Melanoma on Bing News

PHILADELPHIA (AP) — Giving patients with advanced melanoma two Bristol-Myers drugs that work differently held the deadly skin cancer at bay far longer than just one, though the combination's considerable increase in serious side effects raises concerns about how much patients can endure. A study of 142 patients not treated previously found combining Yervoy and Opdivo, which mobilize the body's immune system to target cancer cells, greatly boosted survival over giving Yervoy alone.Read more on NewsOK.com

Sections:  living   
BING NEWS:
  • Study identifies potential pathway to reducing breast cancer brain metastases
    A study led by researchers from the University of Arizona Cancer Center at UArizona Health Sciences identified a biological mechanism that could lead to more effective treatments for breast cancer ...
    06/7/2024 - 5:35 am | View Link
  • Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows
    Across 24 randomized trials involving patients with locally advanced or metastatic disease, ARSI therapy was associated with a 75% higher risk of any-grade cardiovascular (CV) events (risk ratio [RR] ...
    06/6/2024 - 7:37 am | View Link
  • Enzyme research reveals why some cancer drugs cause severe side effects
    Some cancer drugs cause severe side effects because they are not working accurately enough. A team at the University of Würzburg led by biochemist Caroline Kisker has now discovered why. The small ...
    06/5/2024 - 1:00 pm | View Link
  • Discovery paves the way for more specific cancer drugs with fewer side effects
    These inhibitors, which form the basis of many anti-cancer drugs currently in development, disrupt cell division by blocking the USP28 enzyme. The problem is that they often act not only against USP28 ...
    06/5/2024 - 1:00 pm | View Link
  • Evolving standards of care: new treatments for cervical cancer
    Explore the latest breakthroughs in cervical cancer treatment, including Pfizer's Tivdak, recently approved by U.S. regulators.
    06/5/2024 - 3:51 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News